Jessica Moore (she/her)

Future SSO Breast Fellow. BRCA1 Strong. OBGYN Resident @UMiamiHealth@jacksonhealth 🩺 | MD @umiamimedicine 🌴 | BS in Neuroscience @emoryuniversity 🧠

[Elisabetta Bonzano MD, PhD @to_be_elizabeth]

📌 Neoadjuvant Immune Checkpoint Inhibitors Plus Chemotherapy in Early #BreastCancer
A Systematic Review and Meta-Analysis.

https://t.co/ZmtbKUI58g

👉🏻 In this meta-analysis involving 5114 patients
neoadjuvant ICI therapy was associated with improved efficacy outcomes in early-stage TNBC and PD-L1+ HR+/ERBB2- tumors with an acceptable safety profile.
However, in triple-negative breast cancer, no benefit was observed with adjuvant ICI in patients with pCR or residual disease.
Given the financial and toxicity costs associated with ICIs, future research should prioritize identifying patients most likely to benefit from the addition of ICIs to neoadjuvant chemotherapy.

@OncoAlert #OncoAlertAF @JAMAOnc

[JAMA Oncology @JAMAOnc]

This prospective-retrospective translational study of patients enrolled in SOFT was the first study in which a genomic assay was able to predict which premenopausal patients were most likely to benefit from ovarian function suppression. https://t.co/TKEshvcpPU

[JAMA Oncology @JAMAOnc]

Sentinel lymph node biopsy may have similar outcomes as axillary lymph node dissection when most of the patients go on to receive radiation therapy, finds pooled analysis. https://t.co/YnRXV8zPWF

[Jocelyn J. Fitzgerald MD @jjfitzgeraldMD]

Me if prescribing vaginal estrogen was an Olympic sport

[Lucy M. De La Cruz MD @LucyMDeLaCruzMD]

Thank you Sacha for this amazing opportunity to talk about branding and social media in medicine. 🫶🏼 https://t.co/LAZ5Rm96aN

[Kristin E. Rojas MD, FACS, FACOG @kristinrojasmd]

In honor of (belated) #ClinicalTrialsDay, consider referring your #breastcancer #patients in the S. Florida area w/ #GSM +/- painful sex to our #PRP trial! Patients can be any HR status, on or off endocrine. We have enrolled 7/20 patients 🔬⁦so far! https://t.co/GA74IZ0JCy

[Carla Fisher, MD, MBA @CarlaFisherMD]

Practice changing.

[Jessica Moore (she/her) @JessMooreMD]

Shout out to our amazing past breast fellow @AnshumiDesai and current postdoctoral fellow going into PRS on her presentation of the “10 Commandments for A Grisotti Flap” @ASBrS

[Jessica Moore (she/her) @JessMooreMD]

Amazing overview by my mentor @kristinrojasmd on fertility disparities existing in the breast cancer patient population. As @SocSurgOnc @ASRM_org @acog and @NCCN highlight, fertility options should be discussed as early as possible, before treatment starts. ART is SAFE and FAST!

[Ellie Proussaloglou, MD (she/her) @ellieprouss]

Congrats @JenniferPlichta Ashley Stuckey @ASBrS and all of the presenters at the #asbrs24 #highrisk pre-conference!
Some highlights:💡
#HRT is safe & effective after #RRBSO for #pathogenicvariant carriers
#AI #chatbots may be an effective way to ⬆️access to #geneticcounseling

[Carla Fisher, MD, MBA @CarlaFisherMD]

Wow! Huge group of future breast surgeons!! #ASBRS24

[Jessica Moore (she/her) @JessMooreMD]

@ellieprouss @maryam_lustberg @YaleBreast @SmilowCancer @YaleSurgery @The_Breasties Congrats!

[Kristin E. Rojas MD, FACS, FACOG @kristinrojasmd]

Exciting topics at our #ASBrS24 #survivorship pre-course! Check out our AM program agenda below @AnnaWeissMD, Dr. Kathy Calvillo, Dr. Nathalie Johnson, @caragacianu #bcsm #asbs #asbrs #breastsurgeons

[Jessica Moore (she/her) @JessMooreMD]

@SocSurgOnc Amazing talk!

[Society of Surgical Oncology @SocSurgOnc]

🛑✋You will want to make some time in your busy schedule for this one today! Join SSO Women in Cancer Surgery today at 7pm Central to learn How to Get More Done and maximize your day.
Hold Your Spot Now: https://t.co/7sZXIS0QSW

[Ann Partridge MD, MPH @AnnPartridgeMD]

Dr. Jennifer Ligibel presents the first data from the BWEL trial- a lifestyle based intervention results in significant weight-loss in breast cancer survivors! Still waiting to find out if impacts on recurrence @DanaFarber @ALLIANCE_org

[Kristin E. Rojas MD, FACS, FACOG @kristinrojasmd]

Thank you @ASCO for inviting this #surgeon to talk about our women’s #sexaftercancer program at @SylvesterCancer, made possible w/the support of leadership including @SueKesmodelMD @NbmerchantMD @DrSDNimer @UMiamiHealth @UMiamiMedNews #ASCO2023

[Matteo Lambertini, MD PhD @matteolambe]

Finally out in @NEJM results from #POSITIVE trial showing that temporary interruption of #EndocrineTherapy to attempt #pregnancy is safe in #BreastCancer patients: this is wonderful news…super congrats @AnnPartridgeMD @etop_ibcsg et al! @OncoAlert #bcsm

https://t.co/lGLX61heDV

[Rachel S. Rubin, MD @drrachelrubin]

Solid B today.

How are you?

@CanesDavid @daviesbj @JenniferARegala @clavelluro @AshleyGWinter

[Kristin E. Rojas MD, FACS, FACOG @kristinrojasmd]

Check out our hot-off-the-press review outlining why we should rethink the association between #breastcancer and #contraception @umiamimedicine @UMJMHSurgery @univmiami @SylvesterCancer https://t.co/rqZpueRpyV @SanjanaSatish5 @JessMooreMD